Evidence map›Paper›PMID 41644724›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2026

Spinal fluid antibody profile against bacteria demonstrates intrathecal antibody production in demyelinating diseases.

Emily E Polidoro, Nicholas Stosiek, Jon D Laman, Cheryl A Palmer, John D Kriesel

Abstract read
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily E PolidoroDivision of Infectious Disease, Department of Internal Medicine, University of Utah School of Medicine, 3rd Floor North, 30 North Mario Capecchi Drive, Salt Lake City, UT, 84132, USA.ORCID http://orcid.org/0009-0004-7096-6879
Nicholas StosiekDivision of Infectious Disease, Department of Internal Medicine, University of Utah School of Medicine, 3rd Floor North, 30 North Mario Capecchi Drive, Salt Lake City, UT, 84132, USA.
Jon D LamanDepartment of Pathology & Medical Biology, University Medical Center Groningen, Groningen, The Netherlands.
Cheryl A PalmerDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT, 84132, USA.
John D KrieselDivision of Infectious Disease, Department of Internal Medicine, University of Utah School of Medicine, 3rd Floor North, 30 North Mario Capecchi Drive, Salt Lake City, UT, 84132, USA. john.kriesel@hsc.utah.edu.ORCID http://orcid.org/0000-0003-4861-7723

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study follows work establishing multiple sclerosis (MS) microbial candidates from RNA sequencing of human brain samples. A subsequent study demonstrated anti-microbial immune responses in cerebrospinal fluid (CSF) of patients with demyelinating diseases (DD) and other neurologic diseases (OND). We aim to expand evidence for specific anti-microbial responses in CSF of patients with DD. CSF IgG ELISA assays were developed from 20 bacteria identified as MS microbial candidates. CSF responses from patients with DD (N = 16) and OND (N = 8) were determined using commercial CSF as positive and negative controls. CSF reactivity was expressed as ELISA Index (EI) values against each of the lysates. Antibody Index (AI) values were determined by comparing CSF reactivity and diluted serum samples with equivalent IgG concentrations. AI values > 1.5 were considered positive, 1.0-1.49 equivocal, and < 1.0 negative. Most samples from both groups displayed reactivity across all 20 lysates, with an overall rate of 87.8%. CSF EI values were highest against Haemophilus, Aggregatibacter, and Streptococcus, lowest against Veillonella, Fusobacterium, and Alistipes. Twenty-five percent of subjects with DD and 13% with OND had AI > 1.5 to at least one lysate. Clustering of AI values from four DD samples against Bacteroides and Lactobacillus was observed. This serological study shows reactivity against multiple bacteria in CSF from patients with primary DD including MS and OND. Elevated AI in four DD and one OND subject provides evidence for specific intrathecal antibody production in these patients. KEY MESSAGES: This study measured humoral immune responses in the cerebrospinal fluid (CSF) of human subjects with multiple sclerosis (MS) and other demyelinating diseases against 20 candidate bacteria previously identified by sequencing of diseased human brain tissue. The method described here involves diluting CSF to match the serum IgG concentrations, running an ELISA, and calculating an Antibody Index (AI). The methods described here are improved by directly measuring banked CSF and serum IgG concentrations in the laboratory. Several subjects with demyelinating diseases clustered strongly for responses against Bacteroides, Lactobacillus, Akkermansia, and Alistipes, found in the normal flora in the human gut and female genital tract.

Indexed as

Antibodies, BacterialBacteriaDemyelinating DiseasesAdultAgedEnzyme-Linked Immunosorbent AssayFemaleHumansImmunoglobulin GMaleMiddle AgedMultiple SclerosisYoung AdultAntibodies, BacterialImmunoglobulin GBacteriaCerebrospinal fluidDemyelinationMicrobiomeMultiple sclerosisPathogenesisSerology

Identifiers

PMID41644724
PMCPMC12876083

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.